ஷாய் அல்ட்மன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஷாய் அல்ட்மன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஷாய் அல்ட்மன் Today - Breaking & Trending Today

Zenabis receives Malta license for medical cannabis production


Zenabis receives Malta license for medical cannabis production
Zenabis Global’s Maltese joint venture ZenPharm obtains Maltese licence to produce cannabis for medicinal and research purposes,
15 May 2021, 12:52pm
by Matthew Vella
ZenPharm is the second licencee to be given the go-ahead to a medical cannabis licence in Malta
Zenabis Global’s Maltese joint venture ZenPharm has received its Maltese licence to produce cannabis for medicinal and research purposes, after a two-year process by the Malta Medicines Authority.
The receipt of the Medicinal Cannabis License follows on the earlier European Union Good Manufacturing Practices certification issued by Malta Medicines Authority in January 2021. ....

United Kingdom , Shai Altman , Zenabis Atholville , Angele Azzopardi , Malta Medicines Authority , European Union Good Manufacturing Practices , European Union , Zenabis Global , Malta Medicines , Medicinal Cannabis License , Polish Market , Miriam Dalli , ஒன்றுபட்டது கிஂக்டம் , ஷாய் அல்ட்மன் , ஏஞ்சல் அஸ்ஸ்ஒப்பர்டி , மால்டா மருந்துகள் அதிகாரம் , ஐரோப்பிய தொழிற்சங்கம் நல்ல உற்பத்தி ப்ர்யாக்டிஸஸ் , ஐரோப்பிய தொழிற்சங்கம் , மால்டா மருந்துகள் , போலீஷ சந்தை , மிரியம் டல்லி ,

Zenabis Global's JV To Launch Operations In Malta


Zenabis Global Inc. s (TSX:ZENA) Maltese joint venture,
ZenPharm Limited, was given the green light to produce cannabis for medicinal and research purposes in the Mediterranean island country.
The license issued by the Malta Medicines Authority comes on the heels of receipt of the European Union Good Manufacturing Practices certification, which was issued by the same regulatory body in February.
The Canadian cannabis producer is now set to import in bulk from its facility in Atholville.
ZenPharm already inked a supply deal with a customer in Germany to provide a minimum volume of 500 kg per year.
In addition, ZenPharm agreed to accept shipments of up to 300kg from the Atholville-based facility through year-end. ....

United Kingdom , British Columbia , Shai Altman , Malta Medicines Authority , European Union Good Manufacturing Practices , European Union , Zenabis Global Inc , Zenabis Global , Zenpharm Limited , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , ஷாய் அல்ட்மன் , மால்டா மருந்துகள் அதிகாரம் , ஐரோப்பிய தொழிற்சங்கம் நல்ல உற்பத்தி ப்ர்யாக்டிஸஸ் , ஐரோப்பிய தொழிற்சங்கம் ,

Zenabis Global (ZBISF) - Zenabis Reports YOY Revenue Growth, Positive Adjusted EBITDA


Canadian cannabis company,
Zenabis Global Inc. (TSX: ZENA) (OTC:ZBISF) released Wednesday its fourth-quarter and full-year financial results with full-year revenue of $59.3 million.
Full-Year Highlights
Consolidated net revenue jumped 95% from the prior year.
Consolidated adjusted EBITDA came in positive, at $3.5 million, which compares to an adjusted EBITDA loss of $38.7 million in 2019.
Consolidated net loss amounted to $70.5 million or 13 cents per share, compared to $127.0 million or 53 cents per share in the prior year.
The gross margin before fair value changes to biological assets and inventories was $24.8 million or 41.8% of net revenue, versus $13.7 million or 44.9% of net revenue in 2019.
Fourth-Quarter Highlights
Quarterly consolidated net revenue was $15.9 million, up by 50% from $10.6 million in the fourth quarter of 2019. ....

Shai Altman , Zenabis Delta , Zenabis Global Inc , Zenabis Global , Chief Executive Officer , ஷாய் அல்ட்மன் , தலைமை நிர்வாகி அதிகாரி ,

Zenabis Reports YOY Revenue Growth, Positive Adjusted EBITDA


Zenabis Reports YOY Revenue Growth, Positive Adjusted EBITDA
Benzinga
3 days ago
Canadian cannabis company,
Zenabis Global Inc. (TSX: ZENA) (OTC: ZBISF) released Wednesday its fourth-quarter and full-year financial results with full-year revenue of $59.3 million.
Popular Searches
Full-Year Highlights Consolidated net revenue jumped 95% from the prior year. Consolidated adjusted EBITDA came in positive, at $3.5 million, which compares to an adjusted EBITDA loss of $38.7 million in 2019. Consolidated net loss amounted to $70.5 million or 13 cents per share, compared to $127.0 million or 53 cents per share in the prior year. The gross margin before fair value changes to biological assets and inventories was $24.8 million or 41.8% of net revenue, versus $13.7 million or 44.9% of net revenue in 2019. ....

Shai Altman , Zenabis Delta , Zenabis Global Inc , Zenabis Global , Year Highlights Consolidated , Quarter Highlights , Chief Executive Officer , ஷாய் அல்ட்மன் , ஆண்டு சிறப்பம்சங்கள் தொகுக்கப்பட்டு , காலாண்டு சிறப்பம்சங்கள் , தலைமை நிர்வாகி அதிகாரி ,